The Mount Sinai Health System in New York has formed a research affiliation with Stony Brook Medicine, a state-run health system and medical school on New York's Long Island, and will collaborate on research, academic programs, and clinical care initiatives.
Stony Brook said in a statement that the partnership will allow both providers to make new discoveries and expand clinical trials between them.
Mount Sinai's Icahn School of Medicine and Stony Brook University will collaborate to create new research programs in areas including biomedical engineering and computer science; drug discovery and medicinal chemistry sciences; neuroscience, neurology and psychiatry; basic biology and novel therapeutics; and public health.
[Also: Mount Sinai makes bold $500 million 'Mt. Sinai Downtown' modernization]
Stony Brook University is known for its solid mathematics and high-performance computing, imaging, physical and chemical sciences programs. Mount Sinai brings expertise in biomedical and clinical research, as well health policy, Stony Brook said.
"Major breakthroughs in improving diagnostics and therapeutics in healthcare come from research, usually starting at the very basic level and moving into translational and clinical research and eventually to the bedside," said Lina Obeid, MD, Dean for Research and Vice Dean for Scientific Affairs at Stony Brook University School of Medicine.
The two schools will create joint graduate and medical education programs in all areas, and students will be able to take classes on both campuses affording them greater opportunity to learn new techniques. Mount Sinai and Stony Brook will also build summer programs for undergraduate, graduate and postgraduate students, and invest $500,000 to launch competitive pilot programs.
Twitter: @BethJSanborn